• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Kodak adds Cemax-Icon teleradiology

Article

Eastman Kodak has signed an agreement with Cemax-Icon to add thatPACS developer's teleradiology and PACS workstation technologyto Kodak's image management systems. Kodak, of Rochester, NY,would not release details of the new relationship, and

Eastman Kodak has signed an agreement with Cemax-Icon to add thatPACS developer's teleradiology and PACS workstation technologyto Kodak's image management systems. Kodak, of Rochester, NY,would not release details of the new relationship, and Cemax-Iconof Fremont, CA, declined to comment, citing confidentiality issues.

Kodak's Digital Science image management system (formerly knownas Ektascan Imagelink) has a teleradiology component, but theCemax-Icon agreement will give customers additional flexibility.The decision to partner with Cemax-Icon indicates Kodak's growingwillingness to outsource products from other firms rather thandevelop PACS components on its own, according to spokespersonDawn Beck.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.